By targeting a previously unexploited metabolic pathway essential for bacterial survival, the drug candidate may offer the potential to develop safer, shorter and more effective treatment regimens ...

New drugs that target 'zombie' tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of Surrey, published in Scientific Reports.

New drugs that target "zombie" tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of Surrey, published in Scientific Reports.

New drugs that target 'zombie' tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of Surrey, published in Scientific Reports.

New drugs that target 'zombie' tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of Surrey, published in Scientific Reports. Many dangerous pathogens, ...

New breakthrough reveals how to kill ‘zombie’ TB cells that resist antibiotics, offering hope for stronger, more effective tuberculosis treatments.

The U.S. Centers for Disease Control and Prevention estimates nearly 13 million people in the U.S. have “latent TB infection.” ...

We developed a novel therapeutic DNA TB vaccine that promotes immune responses to the stringent response protein RelMtb, which are further enhanced by fusion with a chemokine gene, Macrophage ...

Pediatric TB cases are rising across Europe and Central Asia, indicating ongoing transmission and raising concern around multidrug-resistant strains.

He said, last year, Ghana identified 900 children with tuberculosis infections in the brain, spine and other organs, out of a projected target of 16,000 children. Dr Adusi-Poku said the country ...

Tuberculosis cases linked to an ongoing outbreak in the Kansas City area continue to climb. The outbreak, which began a year ago, killed two people in 2024.

Three compounds isolated from tuberculosis’s fungal foes killed cultured cells of the bacterium that causes the disease, Mycobacterium tuberculosis (Mtb), in lab tests.